Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01667835
Other study ID # KK11-04
Secondary ID
Status Recruiting
Phase Phase 1
First received June 17, 2012
Last updated November 16, 2012
Start date November 2012
Est. completion date August 2015

Study information

Verified date November 2012
Source Kwantlen Polytechnic University
Contact Amandah L Hoogbruin, PhD
Phone 604 599 3144
Email amandah.hoogbruin@kwantlen.ca
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date August 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria:

- 40- 65 years old

- Postmenopausal (amenorrhea for = 12 months)

- Overweight as evidenced by a body mass index (BMI) = 25 kg/m2), or waist circumference = 80 cm, or have a first degree relative with diabetes or essential hypertension

- Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week)

- Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined "as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere

- Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.

Exclusion Criteria:

- Have had a period within the last year

- Are not between the ages of 40 and 65

- Have experience with yoga within the last 12 months

- Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma)

- Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke

- Have a severe infectious or other medical illness right now such as pneumonia

- Use medications to lower blood sugar levels

- Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program

- Regularly use an assistive device (e.g., cane, walker) to walk

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Yoga Intervention
12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Locations

Country Name City State
Canada Kwantlen Polytechnic University Surrey British Columbia
Canada The Jim Pattison Outpatient Care and Surgery Services, Cardiovascular Outpatient Clinic Surrey British Columbia

Sponsors (1)

Lead Sponsor Collaborator
Kwantlen Polytechnic University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood pressure blood pressure is measured as a specific physiologic index of cardiovascular risk. baseline, at end of study (12 wks), & 3 months post-study No
Secondary Change in subjective well-being The Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being. baseline, at end of study (12 wks), & 3 months post-study No
Secondary Change in perceived physical well-being Pittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in insulin sensitivity Fasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in inflammation C-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in serum total cholesterol Serum total cholesterol will be measured as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in serum high-density lipoprotein (HDL) cholesterol Serum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in serum low-density lipoprotein (LDL) cholesterol Serum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in serum triglycerides Serum triglycerides will be measured as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in waist circumference. Waist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change waist-hip ratio Waist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in body mass index (BMI) Body mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in resting heart rate Resting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk baseline, end of study (12 wks) & 3 months post-study No
Secondary Change in heart rate Heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk baseline, at end of study (12 wks), & 3 months post-study No
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Completed NCT02502812 - Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects Phase 1
Recruiting NCT04216342 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers Phase 1
Completed NCT03654313 - Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Phase 1
Completed NCT03646656 - Heart Health Buddies: Peer Support to Decrease CVD Risk N/A
Completed NCT02081066 - Identification of CETP as a Marker of Atherosclerosis N/A
Completed NCT02147626 - Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia N/A
Not yet recruiting NCT06405880 - Pharmacist Case Finding and Intervention for Vascular Prevention Trial N/A
Recruiting NCT03095261 - Incentives in Cardiac Rehabilitation N/A
Completed NCT02711878 - Healing Hearts and Mending Minds in Older Adults Living With HIV N/A
Not yet recruiting NCT02578355 - National Plaque Registry and Database N/A
Completed NCT02868710 - Individual Variability to Aerobic Exercise Training N/A
Completed NCT02589769 - Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons N/A
Completed NCT02998918 - Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL N/A
Recruiting NCT02885792 - Coronary Artery Disease in Patients Suffering From Schizophrenia N/A
Completed NCT02657382 - Mental Stress Ischemia: Biofeedback Study N/A
Completed NCT02640859 - Investigation of Metabolic Risk in Korean Adults
Completed NCT02652975 - Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium N/A
Completed NCT02272946 - Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk Phase 2
Recruiting NCT02265250 - Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment